Pancreatic tumor cell metastasis is restricted by MT1-MMP binding protein MTCBP-1.


Journal

The Journal of cell biology
ISSN: 1540-8140
Titre abrégé: J Cell Biol
Pays: United States
ID NLM: 0375356

Informations de publication

Date de publication:
07 01 2019
Historique:
received: 07 02 2018
revised: 28 09 2018
accepted: 29 10 2018
pubmed: 30 11 2018
medline: 23 10 2019
entrez: 30 11 2018
Statut: ppublish

Résumé

The process by which tumor cells mechanically invade through surrounding stroma into peripheral tissues is an essential component of metastatic dissemination. The directed recruitment of the metalloproteinase MT1-MMP to invadopodia plays a critical role in this invasive process. Here, we provide mechanistic insight into MT1-MMP cytoplasmic tail binding protein 1 (MTCBP-1) with respect to invadopodia formation, matrix remodeling, and invasion by pancreatic tumor cells. MTCBP-1 localizes to invadopodia and interacts with MT1-MMP. We find that this interaction displaces MT1-MMP from invadopodia, thereby attenuating their number and function and reducing the capacity of tumor cells to degrade matrix. Further, we observe an inverse correlation between MTCBP-1 and MT1-MMP expression both in cultured cell lines and human pancreatic tumors. Consistently, MTCBP-1-expressing cells show decreased ability to invade in vitro and metastasize in vivo. These findings implicate MTCBP-1 as an inhibitor of the metastatic process.

Identifiants

pubmed: 30487181
pii: jcb.201802032
doi: 10.1083/jcb.201802032
pmc: PMC6314558
doi:

Substances chimiques

RNA, Small Interfering 0
ADI1 protein, human EC 1.-
Dioxygenases EC 1.13.11.-
MMP14 protein, human EC 3.4.24.80
Matrix Metalloproteinase 14 EC 3.4.24.80

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

317-332

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK084567
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA102701
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA104125
Pays : United States

Informations de copyright

© 2018 Qiang et al.

Références

J Cell Biol. 2001 Dec 24;155(7):1319-32
pubmed: 11756480
Trends Cell Biol. 2013 Jan;23(1):16-21
pubmed: 22999190
J Cell Biol. 2009 Apr 6;185(1):11-9
pubmed: 19332889
J Biol Chem. 2004 Mar 26;279(13):12734-43
pubmed: 14718544
FEBS J. 2018 Jan;285(1):8-27
pubmed: 28548369
J Cell Biol. 2012 Feb 6;196(3):375-85
pubmed: 22291036
CA Cancer J Clin. 2017 Jan;67(1):7-30
pubmed: 28055103
J Vis Exp. 2012 Aug 27;(66):e4119
pubmed: 22952016
Front Cell Dev Biol. 2015 Feb 02;3:4
pubmed: 25699257
Trends Cell Biol. 2017 Aug;27(8):595-607
pubmed: 28412099
Nat Rev Mol Cell Biol. 2011 Jun 23;12(7):413-26
pubmed: 21697900
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13693-8
pubmed: 11698655
Mol Carcinog. 2016 Feb;55(2):148-60
pubmed: 25640948
Cancer Res. 2014 Jun 1;74(11):2913-21
pubmed: 24840647
J Biol Chem. 2012 Mar 30;287(14):11533-45
pubmed: 22315223
PLoS Med. 2010 Jul 13;7(7):e1000307
pubmed: 20644708
J Cell Sci. 2009 Sep 1;122(Pt 17):3015-24
pubmed: 19692588
Curr Opin Cell Biol. 2008 Apr;20(2):235-41
pubmed: 18337078
Mol Biol Cell. 2011 May;22(9):1529-38
pubmed: 21411625
Cancer Res. 2006 Mar 15;66(6):3034-43
pubmed: 16540652
Trends Cell Biol. 2007 Mar;17(3):107-17
pubmed: 17275303
Cell. 2011 Jun 24;145(7):1012-22
pubmed: 21703446
Cancers (Basel). 2014 Feb 17;6(1):416-35
pubmed: 24549119
J Cell Biol. 2000 Oct 2;151(1):187-98
pubmed: 11018064
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30
pubmed: 26742998
J Cell Biol. 2012 Oct 29;199(3):527-44
pubmed: 23091069
Genes Cells. 2005 Jun;10(6):565-74
pubmed: 15938715
Oncol Res. 1996;8(12):469-71
pubmed: 9160350
J Cell Biol. 2016 Apr 11;213(1):109-25
pubmed: 27069022
Cancer Treat Rev. 2012 Oct;38(6):726-36
pubmed: 22342103
PLoS One. 2012;7(2):e30605
pubmed: 22347388
Nat Rev Cancer. 2002 Mar;2(3):161-74
pubmed: 11990853
J Cell Biol. 2009 Apr 20;185(2):357-70
pubmed: 19364917
Cancer Res. 2007 May 1;67(9):4227-35
pubmed: 17483334
J Biol Chem. 2008 Dec 19;283(51):35410-8
pubmed: 18955496

Auteurs

Li Qiang (L)

Biochemistry and Molecular Biology Program, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN.

Hong Cao (H)

Center for Basic Research in Digestive Diseases, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.

Jing Chen (J)

Center for Basic Research in Digestive Diseases, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.

Shaun G Weller (SG)

Center for Basic Research in Digestive Diseases, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.

Eugene W Krueger (EW)

Center for Basic Research in Digestive Diseases, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.

Lizhi Zhang (L)

Department of Laboratory Medicine, Mayo Clinic, Rochester, MN.

Gina L Razidlo (GL)

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN.
Center for Basic Research in Digestive Diseases, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.

Mark A McNiven (MA)

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN mmcniven@mayo.edu.
Center for Basic Research in Digestive Diseases, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH